aTyr Pharma Inc (ATYR) Stock Price, Quote, News & History

ATYRNASDAQ
$0.5590
0.0061.08%
At close: Aug 14, 5:00 PM EST
$0.5291
-0.0299-5.35%
After Hours: Aug 14, 5:19 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-54.54M
Investing Cash Flow (TTM)
22.88M
Financing Cash Flow (TTM)
29.22M
Free Cash Flow (TTM)
-54.82M
Capital Expenditure (TTM)
-279.00K
Net Change in Cash (TTM)
-2.44M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.2
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$9.89M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
283.99
PB Ratio (TTM)
1.11
Earnings Yield % (TTM)
-114.25%
Earnings Yield % (FWD)
-74.36%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.50

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$562.00K
Total Cash
$16.16M
Debt to Equity
0.23
Issuance of Debt (TTM)
-$562.00K
Repayment of Debt (TTM)
-$562.00K

Key Statistics

Open
$0.56
Close
$0.56
Volume / Avg.
656.62K / 2.42M
Day Range
$0.55 - $0.59
52 Wk Range
0.40 - 6.50
Market Cap
$51.90M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
11.42%
Days to Cover
11.76

About

Sector
Health Care
Industry
Biotechnology
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery plat...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy aTyr Pharma (ATYR) stock?

A

You can purchase shares of aTyr Pharma (NASDAQ:ATYR) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for aTyr Pharma (ATYR) stock?

A

aTyr Pharma has a consensus price target of $5.79.

Q

What is the current price for aTyr Pharma (ATYR)?

A

The stock price for aTyr Pharma (NASDAQ: ATYR) is $0.5291 last updated August 14, 2026 at 5:19 PM EDT.

Q

Does aTyr Pharma (ATYR) pay a dividend?

A

There are no upcoming dividends for aTyr Pharma.

Q

When is aTyr Pharma (NASDAQ:ATYR) reporting earnings?

A

aTyr Pharma does not have any upcoming earnings scheduled.

Q

Is aTyr Pharma (ATYR) going to split?

A

There is no upcoming split for aTyr Pharma.

Q

What sector and industry does aTyr Pharma (ATYR) operate in?

A

aTyr Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.